<?xml version='1.0' encoding='utf-8'?>
<document id="16595711"><sentence text="Drug-drug interaction between pitavastatin and various drugs via OATP1B1."><entity charOffset="30-42" id="DDI-PubMed.16595711.s1.e0" text="pitavastatin" /></sentence><sentence text="It has already been demonstrated that pitavastatin, a novel potent HMG-coenzyme A reductase inhibitor, is taken up into human hepatocytes mainly by organic anion transporting polypeptide (OATP) 1B1"><entity charOffset="38-50" id="DDI-PubMed.16595711.s2.e0" text="pitavastatin" /></sentence><sentence text=" Because OATP2B1 is also localized in the basolateral membrane of human liver, we took two approaches to further confirm the minor contribution of OATP2B1 to the hepatic uptake of pitavastatin"><entity charOffset="180-192" id="DDI-PubMed.16595711.s3.e0" text="pitavastatin" /></sentence><sentence text=" Western blot analysis revealed that the ratio of the band density of OATP2B1 in human hepatocytes to that in our expression system is at least 6-fold lower compared with OATP1B1 and OATP1B3" /><sentence text=" The uptake of pitavastatin in human hepatocytes could be inhibited by both estrone-3-sulfate (OATP1B1/OATP2B1 inhibitor) and estradiol-17beta-D-glucuronide (OATP1B1/OATP1B3 inhibitor)"><entity charOffset="15-27" id="DDI-PubMed.16595711.s5.e0" text="pitavastatin" /><entity charOffset="76-93" id="DDI-PubMed.16595711.s5.e1" text="estrone-3-sulfate" /><entity charOffset="95-102" id="DDI-PubMed.16595711.s5.e2" text="OATP1B1" /><entity charOffset="126-156" id="DDI-PubMed.16595711.s5.e3" text="estradiol-17beta-D-glucuronide" /><pair ddi="false" e1="DDI-PubMed.16595711.s5.e0" e2="DDI-PubMed.16595711.s5.e0" /><pair ddi="false" e1="DDI-PubMed.16595711.s5.e0" e2="DDI-PubMed.16595711.s5.e1" /><pair ddi="false" e1="DDI-PubMed.16595711.s5.e0" e2="DDI-PubMed.16595711.s5.e2" /><pair ddi="false" e1="DDI-PubMed.16595711.s5.e0" e2="DDI-PubMed.16595711.s5.e3" /><pair ddi="false" e1="DDI-PubMed.16595711.s5.e1" e2="DDI-PubMed.16595711.s5.e1" /><pair ddi="false" e1="DDI-PubMed.16595711.s5.e1" e2="DDI-PubMed.16595711.s5.e2" /><pair ddi="false" e1="DDI-PubMed.16595711.s5.e1" e2="DDI-PubMed.16595711.s5.e3" /><pair ddi="false" e1="DDI-PubMed.16595711.s5.e2" e2="DDI-PubMed.16595711.s5.e2" /><pair ddi="false" e1="DDI-PubMed.16595711.s5.e2" e2="DDI-PubMed.16595711.s5.e3" /></sentence><sentence text=" These results further supported the idea that OATP1B1 is a predominant transporter for the hepatic uptake of pitavastatin"><entity charOffset="110-122" id="DDI-PubMed.16595711.s6.e0" text="pitavastatin" /></sentence><sentence text=" Then, to explore the possibility of OATP1B1-mediated drug-drug interaction, we checked the inhibitory effects of various drugs on the pitavastatin uptake in OATP1B1-expressing cells and evaluated whether the in vitro inhibition was clinically significant or not"><entity charOffset="135-147" id="DDI-PubMed.16595711.s7.e0" text="pitavastatin" /></sentence><sentence text=" As we previously reported, we used the methodology for estimating the maximum unbound concentration of inhibitors at the inlet to the liver (I(u,in,max))" /><sentence text=" Judging from I(u,in,max) and inhibition constant (K(i)) for OATP1B1, several drugs (especially cyclosporin A, rifampicin, rifamycin SV, clarithromycin, and indinavir) have potentials for interacting with OATP1B1-mediated uptake of pitavastatin"><entity charOffset="96-109" id="DDI-PubMed.16595711.s9.e0" text="cyclosporin A" /><entity charOffset="111-121" id="DDI-PubMed.16595711.s9.e1" text="rifampicin" /><entity charOffset="123-135" id="DDI-PubMed.16595711.s9.e2" text="rifamycin SV" /><entity charOffset="137-151" id="DDI-PubMed.16595711.s9.e3" text="clarithromycin" /><entity charOffset="157-166" id="DDI-PubMed.16595711.s9.e4" text="indinavir" /><entity charOffset="232-244" id="DDI-PubMed.16595711.s9.e5" text="pitavastatin" /><pair ddi="false" e1="DDI-PubMed.16595711.s9.e0" e2="DDI-PubMed.16595711.s9.e0" /><pair ddi="false" e1="DDI-PubMed.16595711.s9.e0" e2="DDI-PubMed.16595711.s9.e1" /><pair ddi="false" e1="DDI-PubMed.16595711.s9.e0" e2="DDI-PubMed.16595711.s9.e2" /><pair ddi="false" e1="DDI-PubMed.16595711.s9.e0" e2="DDI-PubMed.16595711.s9.e3" /><pair ddi="false" e1="DDI-PubMed.16595711.s9.e0" e2="DDI-PubMed.16595711.s9.e4" /><pair ddi="false" e1="DDI-PubMed.16595711.s9.e0" e2="DDI-PubMed.16595711.s9.e5" /><pair ddi="false" e1="DDI-PubMed.16595711.s9.e1" e2="DDI-PubMed.16595711.s9.e1" /><pair ddi="false" e1="DDI-PubMed.16595711.s9.e1" e2="DDI-PubMed.16595711.s9.e2" /><pair ddi="false" e1="DDI-PubMed.16595711.s9.e1" e2="DDI-PubMed.16595711.s9.e3" /><pair ddi="false" e1="DDI-PubMed.16595711.s9.e1" e2="DDI-PubMed.16595711.s9.e4" /><pair ddi="false" e1="DDI-PubMed.16595711.s9.e1" e2="DDI-PubMed.16595711.s9.e5" /><pair ddi="false" e1="DDI-PubMed.16595711.s9.e2" e2="DDI-PubMed.16595711.s9.e2" /><pair ddi="false" e1="DDI-PubMed.16595711.s9.e2" e2="DDI-PubMed.16595711.s9.e3" /><pair ddi="false" e1="DDI-PubMed.16595711.s9.e2" e2="DDI-PubMed.16595711.s9.e4" /><pair ddi="false" e1="DDI-PubMed.16595711.s9.e2" e2="DDI-PubMed.16595711.s9.e5" /><pair ddi="false" e1="DDI-PubMed.16595711.s9.e3" e2="DDI-PubMed.16595711.s9.e3" /><pair ddi="false" e1="DDI-PubMed.16595711.s9.e3" e2="DDI-PubMed.16595711.s9.e4" /><pair ddi="false" e1="DDI-PubMed.16595711.s9.e3" e2="DDI-PubMed.16595711.s9.e5" /><pair ddi="false" e1="DDI-PubMed.16595711.s9.e4" e2="DDI-PubMed.16595711.s9.e4" /><pair ddi="false" e1="DDI-PubMed.16595711.s9.e4" e2="DDI-PubMed.16595711.s9.e5" /></sentence><sentence text=" The in vitro experiments could support the clinically observed drug-drug interaction between pitavastatin and cyclosporin A"><entity charOffset="94-106" id="DDI-PubMed.16595711.s10.e0" text="pitavastatin" /><entity charOffset="111-124" id="DDI-PubMed.16595711.s10.e1" text="cyclosporin A" /><pair ddi="false" e1="DDI-PubMed.16595711.s10.e0" e2="DDI-PubMed.16595711.s10.e0" /><pair ddi="false" e1="DDI-PubMed.16595711.s10.e0" e2="DDI-PubMed.16595711.s10.e1" /></sentence><sentence text=" These results suggest that we should pay attention to the concomitant use of some drugs with pitavastatin"><entity charOffset="94-106" id="DDI-PubMed.16595711.s11.e0" text="pitavastatin" /></sentence><sentence text="" /></document>